Cancer researchers retract two papers in the JBC
Two cancer researchers who hold a patent on a particular pathway that might be a target for new drugs — and one of whom leads a company that is studying those potential drugs — have retracted two related papers in the Journal of Biological Chemistry (JBC). The notices for “Kinase suppressor of Ras signals through … Continue reading Cancer researchers retract two papers in the JBC